Interchangeable Insulin Biosimilars: A Game Changer in Diabetes Management
November 30th 2021The panel of experts in the management of diabetes review the role of insulin therapy and the place for biosimilars. They will review the approval process for biosimilars including the approval of the first interchangeable insulin biosimilar.